Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic aspects of scleroderma

B Kahaleh1

  • 1Division of Rheumatology, Medical College of Ohio, Toledo 43699.

Current Opinion in Rheumatology
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

The precise trigger for scleroderma remains unknown, but research highlights immune cell interactions with vascular endothelium and the role of autoantigens like nucleolar proteins. Further study is needed to identify specific T cell phenotypes involved in this autoimmune disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of the dermatologist in Raynaud's phenomenon: a clinical challenge.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same author

There is a need for new systemic sclerosis subset criteria. A content analytic approach.

Scandinavian journal of rheumatology·2017
Same author

The microvascular endothelium in scleroderma.

Rheumatology (Oxford, England)·2008
Same author

Assessment of vascular involvement.

Clinical and experimental rheumatology·2003
Same author

An elderly man with vasculitis and IgA myeloma.

Journal of the European Academy of Dermatology and Venereology : JEADV·1998
Same author

Raynaud's phenomenon and systemic sclerosis.

Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna·1996
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Area of Science:

  • Immunology
  • Rheumatology
  • Cell Biology

Background:

  • Immune involvement in scleroderma is established, yet the exact trigger is elusive.
  • Early scleroderma changes involve immune cell-endothelial interactions and adhesion molecules.
  • The nucleolus is a primary autoantigen molecular structure in scleroderma.

Purpose of the Study:

  • To define mechanisms of immune activation in scleroderma.
  • To investigate the nature of autoantigens and cytokine networks.
  • To characterize immune cell participation and T cell phenotypes in scleroderma.

Main Methods:

  • Analysis of immune cell-endothelial interactions and adhesion molecule cascades.
  • Investigation of autoantigen localization, including nucleolar structures.

Related Experiment Videos

  • Assessment of cytokine expression (IL-1, IL-6) by fibroblasts and autoantibodies to cytokines (IL-6, IL-8).
  • Evaluation of circulating markers of T cell activation and V beta gene usage in double-negative T cells.

    • Main Results:

    • Early vascular endothelium changes and adhesion molecule involvement are documented.
    • Fibroblasts demonstrate enhanced responses to IL-1 and IL-6, producing immune mediators.
    • Circulating autoantibodies to IL-6 and IL-8 suggest complex cytokine network regulation.
    • Restricted V beta gene usage in double-negative alpha/beta T cells points to them as potential alloreactive cells.

    Conclusions:

    • While the precise trigger for scleroderma is unknown, immune cell-endothelial interactions and cytokine dysregulation are key features.
    • The nucleolus is identified as a primary autoantigenic structure.
    • Further research is needed to elucidate the exact phenotype of effector T cells in scleroderma, with double-negative T cells as a potential candidate.